Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights.
OBJECTIVE
Glycosaminoglycans (GAG) are major components of bone marrow extracellular matrix because they have the property to interact with cells and growth factors in hematopoietic niches. In this study, we investigated the effect of two different chemically defined GAG mimetics on mobilization of hematopoietic stem and progenitor cells (HSPCs) in mice peripheral blood.


METHODS
Mobilization was achieved by intraperitoneal injection of GAG mimetics. Mobilized cells were characterized phenotypically by reverse transcription polymerase chain reaction and fluorescence-activated cell sorting analysis and functionally by colony-forming cell, cobblestone area-forming cell and long-term culture-initiating cell assays in vitro. Radioprotection assays were performed to confirm the functionality of primitive hematopoietic cells in vivo. Involvement of stromal-derived factor-1 (SDF-1) and matrix metalloproteinase-9 (MMP-9) were investigated.


RESULTS
GAG mimetics treatment induces hyperleukocytosis and mobilization of HSPC. They synergize with the effects of granulocyte colony-stimulating factor or AMD3100 on hematopoietic progenitors mobilization. Reconstitution of lethally irradiated recipient mice with peripheral blood mononuclear cells from GAG mimetic-treated donor mice improves engraftment and survival. BiAcore studies indicate that the mimetics interact directly with SDF-1. In addition, GAG mimetics-induced mobilization is associated with increased levels of pro- and active MMP-9 from bone marrow cells and increased level of SDF-1 in peripheral blood. Finally, mobilization is partially inhibited by co-injection with anti-SDF-1 antibody.


CONCLUSIONS
This study demonstrates that GAG mimetics induce efficient mobilization of HSPCs, associated with an activation of pro-MMP-9 and a modification in the SDF-1 concentration gradient between bone marrow and peripheral blood. We suggest that structural features of GAGs can modify the nature of mobilized cells.
Albanese
Patricia
P
CNRS UMR 7149, Laboratoire CRRET, Croissance Cellulaire, Réparation et Régénération Tissulaire, Créteil, France. albanese@univ-paris12.fr
Caruelle
Danielle
D
Frescaline
Guilhem
G
Delbé
Jean
J
Petit-Cocault
Laurence
L
Huet
Eric
E
Charnaux
Nathalie
N
Uzan
Georges
G
Papy-Garcia
Dulce
D
Courty
José
J
D000818:Animals; D019380:Anti-HIV Agents / Q000819:agonists / Q000494:pharmacology; D001596:Benzylamines; D040761:Biomimetic Materials / Q000494:pharmacology*; D001853:Bone Marrow / Q000378:metabolism; D054377:Chemokine CXCL12 / Q000097:blood*; D000080027:Cyclams; D004357:Drug Synergism; D006025:Glycosaminoglycans / Q000819:agonists / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000819:agonists / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D006571:Heterocyclic Compounds / Q000819:agonists / Q000494:pharmacology; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000097:blood*; D051379:Mice; D013329:Structure-Activity Relationship; D014184:Transplantation, Homologous
D019380:Anti-HIV Agents; D001596:Benzylamines; D054377:Chemokine CXCL12; C515256:Cxcl12 protein, mouse; D000080027:Cyclams; D006025:Glycosaminoglycans; D006571:Heterocyclic Compounds; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D020780:Matrix Metalloproteinase 9; C501830:Mmp9 protein, mouse; C088327:plerixafor